针对失眠的新型心理治疗方法
Marie Angelillo1, Jaap Lancee2, Elisabeth Hertenstein1
1Department of Psychiatry, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
失眠的认知行为疗法 (CBT-I) 是一种主要的治疗方法. 未来的方向包括优化CBT-I,为不响应者开发新的疗法,如对失眠的接受和承诺疗法 (ACT-I),以及改善对失眠心理治疗的广泛准入.
科学领域:
- 精神病学是一个精神病学.
- 睡眠医学 睡眠医学
- 行为科学 行为科学
背景情况:
- 失眠障碍很常见,影响睡眠质量和白天功能.
- 失眠的认知行为疗法 (CBT-I) 是主要的治疗方法.
- 优化失眠心理治疗对于患者的福祉至关重要.
研究的目的:
- 概述未来的方向,以优化失眠的心理治疗方法.
- 探索CBT-I有效性和实施的增强方法.
- 确定管理治疗未响应患者的策略.
主要方法:
- 审查和综合当前的研究和临床观点.
- 确定未来研发的有希望领域.
- 讨论潜在的治疗优化策略,包括适应性协议和辅助疗法.
主要成果:
- 优化CBT-I可能涉及理解机制和适应性策略.
- 运动和昼夜干预等辅助疗法对子组显示有前途.
- 接受和承诺治疗失眠 (ACT-I) 是CBT-I不响应患者的潜在选择.
- 改善实施需要简短,有针对性和数字化处理.
结论:
- 需要对治疗机制和不响应者的进一步研究.
- 对CBT-I无反应者的随机对照试验至关重要.
- 实施科学是促进失眠心理治疗的关键.
更多相关视频
05:59Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
相关概念视频
Management of Insomnia
Insomnia
Multiple factors contribute...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Antidepressant Drugs: MAOIs and Other Agents
